Correction: Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR–mediated DNA Damage ResponseLi Ding, Daniel D. Billadeau, Andrey Ugolkov et al.|Clinical Cancer Research|2019Cited by 75
Abstract 2926: The glycogen synthase kinase-3 inhibitor, 9-ING-41, synergizes with chemotherapy to inhibit pancreatic tumor growth in vivoLi Ding, Daniel D. Billadeau, Jin‐San Zhang et al.|Cancer Research|2018Cited by 0